Abstract:Background: The identification of compound-protein interactions (CPIs) is crucial for drug discovery and understanding mechanisms of action. Accurate CPI prediction can elucidate drug-target-disease interactions, aiding in the discovery of candidate compounds and effective synergistic drugs, particularly from traditional Chinese medicine (TCM). Existing in silico methods face challenges in prediction accuracy and generalization due to compound and target diversity and the lack of largescale interaction datasets and negative datasets for model learning. Methods: To address these issues, we developed a computational model for CPI prediction by integrating the constructed large-scale bioactivity benchmark dataset with a deep learning (DL) algorithm. To verify the accuracy of our CPI model, we applied it to predict the targets of compounds in TCM. An herb pair of Astragalus membranaceus and Hedyotis diffusaas was used as a model, and the active compounds in this herb pair were collected from various public databases and the literature. The complete targets of these active compounds were predicted by the CPI model, resulting in an expanded target dataset. This dataset was next used for the prediction of synergistic antitumor compound combinations. The predicted multi-compound combinations were subsequently examined through in vitro cellular experiments. Results: Our CPI model demonstrated superior performance over other machine learning models, achieving an area under the Receiver Operating Characteristic curve (AUROC) of 0.98, an area under the precision-recall curve (AUPR) of 0.98, and an accuracy (ACC) of 93.31% on the test set. The model's generalization capability and applicability were further confirmed using external databases. Utilizing this model, we predicted the targets of compounds in the herb pair of Astragalus membranaceus and Hedyotis diffusaas, yielding an expanded target dataset. Then, we integrated this expanded target dataset to predict effective drug combinations using our drug synergy prediction model DeepMDS. Experimental assay on breast cancer cell line MDA-MB-231 proved the efficacy of the best predicted multi-compound combinations: Combination I (Epicatechin, Ursolic acid, Quercetin, Aesculetin and Astragaloside IV) exhibited a half-maximal inhibitory concentration (IC50) value of 19.41 μM, and a combination index (CI) value of 0.682; and Combination II (Epicatechin, Ursolic acid, Quercetin, Vanillic acid and Astragaloside IV) displayed a IC50 value of 23.83 μM and a CI value of 0.805. These results validated the ability of our model to make accurate predictions for novel CPI data outside the training dataset and evaluated the reliability of the predictions, showing good applicability potential in drug discovery and in the elucidation of the bioactive compounds in TCM. Conclusion: Our CPI prediction model can serve as a useful tool for accurately identifying potential CPI for a wide range of proteins, and is expected to facilitate drug research, repurposing and support the understanding of TCM.

An optimized method for dose–effect prediction of traditional Chinese medicine based on 1D-ResCNN-PLS

Dose-effect relationship analysis of TCM based on deep Boltzmann machine and partial least squares

A non-linear partial least squares based on monotonic inner relation

Combining Convolutional Neural Networks and On-Line Raman Spectroscopy for Monitoring the Cornu Caprae Hircus Hydrolysis Process.

TIRPnet: Risk prediction of traditional Chinese medicine ingredients based on a deep neural network

Drug Side Effect Prediction Through Linear Neighborhoods and Multiple Data Source Integration

Prediction of Radiation Pneumonitis with Dose Distribution: A Convolutional Neural Network (CNN) Based Model

Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network

Softmax Regression and Particle Swarm Optimization with Taboos and a Heuristic Strategy for Dose-effect Data Fitting

Drug-likeness Analysis of Traditional Chinese Medicines: Prediction of Drug-Likeness Using Machine Learning Approaches.

Intelligent algorithm based on deep learning to predict the dosage for anesthesia: A study on prediction of drug efficacy based on deep learning

[A Method for Predicting Activity of Traditional Chinese Medicine Based on Quantitative Composition-Activity Relationship of Neural Network Model].

Pioneering Data Processing for Convolutional Neural Networks to Enhance the Diagnostic Accuracy of Traditional Chinese Medicine Pulse Diagnosis for Diabetes

DBDNMF: A Dual Branch Deep Neural Matrix Factorization method for drug response prediction

A method combining LDA and neural networks for antitumor drug efficacy prediction

A Hierarchical Attention Network Integrating Multi-Scale Relationship for Drug Response Prediction

Drug Efficacy Prediction in Tumors Based on LDA Model

Accurate prediction of drug-target interactions in Chinese and western medicine by the CWI-DTI model

IHPreten: A Novel Supervised Learning Framework with Attribute Regularization for Prediction of Incompatible Herb Pair in Traditional Chinese Medicine

A general prediction model for compound-protein interactions based on deep learning

Radiation Dose Prediction for Pancreatic Stereotactic Body Radiotherapy Via Convention Neural Networks.